SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
NARWOLD KAREN G

(Last) (First) (Middle)
ALBEMARLE CORPORATION
4250 CONGRESS STREET, SUITE 900

(Street)
CHARLOTTE NC 28209

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Chief Admin Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/28/2023
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 558.59 I Albemarle Savings Plan(1)
Common Stock 02/28/2023 M 1,680(2) A $0 12,048 D
Common Stock 02/28/2023 F 751(3) D $254.31 11,297 D
Common Stock 02/28/2023 A 3,360(4) A $0 14,657 D
Common Stock 02/28/2023 F 1,502(5) D $254.31 13,155 D
Common Stock 02/28/2023 A 3,360(6) A $0 16,515 D
Common Stock 02/28/2023 F 1,502(5) D $254.31 15,013 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (7) 02/28/2023 M 1,680 (2) (8) Common Stock 1,680 $0 1,680 D
Performance Stock Units (9) 02/28/2023 A 3,360 (4) (8) Common Stock 3,360 $0 3,360 D
Performance Stock Units (9) 02/28/2023 A 3,360 (6) (8) Common Stock 3,360 $0 3,360 D
Explanation of Responses:
1. Total number of shares of Common Stock held in the name of the Reporting Person under the Albemarle Corporation Retirement Savings Plan (the "Albemarle Savings Plan") as of the date of this Form 4.
2. Restricted Stock Units granted on 02/28/2020. 50% vested on 02/28/2023 and 50% vests on 02/28/2024.
3. Shares withheld to meet tax liabilities associated with vesting of Restricted Stock Units.
4. rTSR Performance Stock Units granted on 02/28/2020. 50% vested 02/28/2023 and 50% vests 01/01/2024.
5. Shares withheld to meet tax liabilities associated with vesting of Performance Stock Units.
6. ROIC Performance Stock Units granted on 02/28/2020. 50% vested 02/28/2023 and 50% vests 01/01/2024.
7. Each Restricted Stock Unit converts to 1 share of Common Stock.
8. No expiration date.
9. Each Performance Stock Unit converts to 1 share of Common Stock.
Remarks:
/s/ Stefanie M. Holland, Attorney-in-Fact 03/02/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.